Which organ is responsible for metabolizing ibuprofen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ibuprofen Metabolism

The liver is the primary organ responsible for metabolizing ibuprofen. 1

Hepatic Metabolism Pathway

Ibuprofen undergoes rapid hepatic metabolism with approximately 45-79% of the dose recovered in urine within 24 hours as metabolites 1. The drug is metabolized through the following pathways:

  • Metabolite A (25%): (+)-2-[p-(2hydroxymethyl-propyl) phenyl] propionic acid
  • Metabolite B (37%): (+)-2-[p-(2carboxypropyl)phenyl] propionic acid
  • Free and conjugated ibuprofen: Approximately 1% and 14%, respectively 1

The serum half-life is 1.8 to 2.0 hours, and excretion is virtually complete within 24 hours after the last dose 1.

Specific Hepatic Enzyme Systems

Cytochrome P450 enzymes, particularly CYP2C9 and CYP2C8, are responsible for the oxidative metabolism of ibuprofen 2. Research demonstrates that:

  • CYP2C9 (both Arg 144 and Cys 144 variants) favors formation of S-2- and S-3-hydroxyibuprofen metabolites
  • CYP2C8 preferentially forms R-2-hydroxyibuprofen 2
  • Both 2-hydroxylation and 3-hydroxylation occur with stereoselective and regioselective patterns 2

Long-term administration of ibuprofen has been shown to induce metabolic activity of CYP450 enzymes 3, though this effect appears to be well-tolerated clinically.

Clinical Implications in Hepatic Dysfunction

NSAIDs including ibuprofen should be avoided in patients with liver cirrhosis 4. In patients with liver disease:

  • Higher concentrations of free (unbound) drug occur, increasing risk of side effects and toxicity 4
  • NSAIDs are responsible for 10% of drug-induced hepatitis cases 4
  • Additional risks include nephrotoxicity, gastric bleeding, and hepatic decompensation 4

The 2022 KLCA-NCC Korea Practice Guidelines specifically recommend that NSAIDs must be avoided as much as possible in patients with liver cirrhosis due to these compounded risks 4.

Human chimeric mouse models have confirmed that hepatic metabolism patterns in humans accurately reflect the quantitative metabolic profiles mediated by both P450 and non-P450 pathways in the liver 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.